Related Experiment Video
Updated: Jul 18, 2026

Electrophysiology on Isolated Brainstem-spinal Cord Preparations from Newborn Rodents Allows Neural Respiratory Network Output Recording
Published on: November 19, 2015
Respiratory inhibition after crying in infants
Hideki Minowa1, Satomi Kubo, Hiroyuki Yoshizawa
1Division of Pediatrics, Nara Hospital, Kinki University School of Medicine, Ikoma, Nara, Japan. nicu@m3.kcn.ne.jp
Insights
Cranial ultrasonography can identify full-term neonates at risk for respiratory inhibition after crying, a condition marked by decreased SpO2. Theophylline effectively treated these episodes, suggesting a potential preventative screening method.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
Background:
- Full-term neonates can experience respiratory inhibition post-crying, characterized by significant SpO2 decrease.
- Associated cranial findings include increased echogenicity or cysts in the ganglionic eminence or subependymal region.
Purpose of the Study:
- To prospectively examine the link between post-crying respiratory inhibition and specific cranial ultrasound findings.
- To investigate potential prevention and treatment strategies for this neonatal episode.
Main Methods:
- Cranial ultrasonography screened 381 full-term neonates.
- Polygraphy was performed on neonates with identified cranial abnormalities (n=104) and a control group (n=50).
- Respiratory inhibition was defined as central apnea post-crying with SpO2 <60%.
Main Results:
- 104 of 381 neonates had cranial abnormalities; 60 experienced respiratory inhibition.
- Oxygen therapy was ineffective for 17 neonates with severe inhibition.
- Theophylline successfully treated episodes, normalizing SpO2, and was discontinued by 6 months.
Conclusions:
- Respiratory inhibition with SpO2 decrease after crying occurs in term neonates without other birth abnormalities.
- Cranial ultrasonography is a viable screening tool for identifying at-risk neonates.
Background:
Among full-term neonates, the authors discovered infants who showed respiratory inhibition after crying which involved a marked decrease in SpO2. The infants were found to present increased echogenicity or a cyst in a cranial region termed the ganglionic eminence, or to have a subependymal cyst. The authors prospectively examined the relationship between respiratory inhibition after crying and these changes to examine the prevention and treatment of the episode.
Methods:
The authors conducted cranial ultrasonography to screen 381 full-term neonates who showed no abnormalities at birth and whose parents requested ultrasonographic screening of the head, followed by polygraphy of infants who showed increased echogenicity or a cyst in ganglionic eminence, or had a subependymal cyst. The authors similarly conducted polygraphy for 50 neonates without cranial ultrasound abnormalities; the former constituted the control group. Respiratory inhibition was defined to be central apnea immediately after crying with a decrease in SpO2 to <60%.
Results:
Among 381 neonates examined, 104 showed cranial ultrasound abnormalities; 60 of the 104 neonates indicated respiratory inhibition after crying. Oxygenation failed to improve the episode in 17 neonates with severe respiratory inhibition. However, theophylline alleviated the episode, and SpO2 no longer decreased to <60%. Theophylline was discontinued successfully by 6 months after birth, while 50 neonates in the control group showed no respiratory inhibition after crying.
Conclusion:
Respiratory inhibition after crying which involved a marked decrease in SpO2 was observed in full-term neonates who showed no abnormalities after birth. These neonates could be screened by cranial ultrasonography.
Related Concept Videos
Pulmonary Cycle: Exhalation
Breathing
Other Factors Affecting Respiration Centers
However, the ability to hold one's breath voluntarily is not limitless. When the CO2 concentration in the blood reaches a critical level,...
Acute Respiratory Failure-IV
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Respiratory Syncytial Virus Disease
